President, CEO, 10% Owner of BioReference Laboratories Inc. (BRLI, Financial) Marc Grodman sells 6,905 shares of BRLI on 12/23/2009 at an average price of $38.53 a share.
BioReference Laboratories Inc. is the largest independent regional clinical laboratory in the Northeast & has major market positions in physician offices, nursing homes & correctional institutions. The Company is a full service clinical laboratory with specialty capability, especially in the areas of genomics, oncology, correctional health & complimentary medicine. PSIMedica, a business unit of the Company is a clinical knowledge management organization offering an array of information solutions for reducing healthcare costs & improving quality performance that are based on a flexible, scalable software analytical engine that utilizes all available source information including claims data, enrollment data, prescription data & laboratory data. They provides a comprehensive connectivity solution to physicians as well as other laboratories which includes laboratory reporting & ordering as well as laboratory to physician communications & cumulative reporting through CareEvolve its Bioreference Laboratories Inc. has a market cap of $534.8 million; its shares were traded at around $38.67 with a P/E ratio of 26 and P/S ratio of 1.4. Bioreference Laboratories Inc. had an annual average earning growth of 19.8% over the past 5 years.
BioReference Laboratories Inc. is the largest independent regional clinical laboratory in the Northeast & has major market positions in physician offices, nursing homes & correctional institutions. The Company is a full service clinical laboratory with specialty capability, especially in the areas of genomics, oncology, correctional health & complimentary medicine. PSIMedica, a business unit of the Company is a clinical knowledge management organization offering an array of information solutions for reducing healthcare costs & improving quality performance that are based on a flexible, scalable software analytical engine that utilizes all available source information including claims data, enrollment data, prescription data & laboratory data. They provides a comprehensive connectivity solution to physicians as well as other laboratories which includes laboratory reporting & ordering as well as laboratory to physician communications & cumulative reporting through CareEvolve its Bioreference Laboratories Inc. has a market cap of $534.8 million; its shares were traded at around $38.67 with a P/E ratio of 26 and P/S ratio of 1.4. Bioreference Laboratories Inc. had an annual average earning growth of 19.8% over the past 5 years.
CEO Recent Trades:
- Sell:: President, CEO, 10% Owner Marc Grodman sold 29,196 shares of BRLI stock on 10/07/2009 at the average price of 35.19, the price of the stock has increased by 9.89% since.
- Sell:: President, CEO, 10% Owner Marc Grodman sold 35,000 shares of BRLI stock on 07/09/2009 at the average price of 30.37, the price of the stock has increased by 27.33% since.
CFO Recent Trades:
- Sell:: Sr. VP, Sec'y, Treasurer, CFO Sam Singer sold 4,300 shares of BRLI stock on 09/04/2009 at the average price of 34.76, the price of the stock has increased by 11.25% since.
- Sell:: Sr. VP, Sec'y, Treasurer, CFO Sam Singer sold 16,500 shares of BRLI stock on 07/14/2009 at the average price of 30, the price of the stock has increased by 28.9% since.
Directors and Officers Recent Trades:
- Sell:: Executive VP, COO Howard Dubinett sold 85,803 shares of BRLI stock on 10/19/2009 at the average price of 29.98, the price of the stock has increased by 28.99% since.
- Sell:: Director Gary Lederman sold 12,000 shares of BRLI stock on 10/05/2009 at the average price of 35.24, the price of the stock has increased by 9.73% since.
